Nutriband receives Korean patent for abuse-deterrent transdermal system AVERSA

NutriBand Inc.

Korean Intellectual Property Office issued full patent titled 'Abuse and Misuse Deterrent Transdermal System'.
Patent supports 4p Therapeutics' AVERSA fentanyl transdermal system using taste aversion.
Company previously received notice of allowance in December 2020.

item 7.01 item 9.01

NutriBand Inc. filing history →

Source: SEC EDGAR

accession 0001213900-22-000118

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.